Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

Overview of attention for article published in Frontiers in oncology, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,787 followers.

Can Lapatinib be poor man's Pertuzumab in 1st line mBC. @Abhishe13529795 @snebothra

29 Jul 2020

Reply Repost Favourite

@Amolpatel_dr @snebothra @Abhishe13529795 https://t.co/mC5w5ry72W

29 Jul 2020

Reply Repost Favourite

New research: Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study: Introduction: Combination of trastuzumab (T) and lapatinib (L) has… https://t.co/

06 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.